Hepatitis C virus infection and HCV genotypes of hemodialysis patients

Iranian Journal of Public Health

Volumn 37, Issue 3, 2008, Pages 146-152

  Samimi Rad, K ^a   Hosseini, M ^a   Shahbaz, B ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HCV genotypes; Hemodialysis; Hepatitis C virus; Iran

Indexed keywords

EID: 56549084000     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Folsch UR, Schmidt WE (2002). Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients: a multicenter study in 2796 patients. Gut, 51: 429-33.
2. Hmaied F, Ben Mamou M, Saune-Sandres K, Rostaing L, Slim A, Arrouji Z, Ben Redjeb S, Izopet J (2006). Hepatitis C virus infection among dialysis patients in Tunisia: Incidence and molecular evidence for nosocomial transmission. J Med Virol, 78: 185-91.
3. Saxena AK, Panhotra BR (2004). The vulnerability of middle-aged and elderly patients to hepatitis C virus infection in a high-prevalence hospital-based hemodialysis setting. J Am Geriatr Soc, 52: 242-46.
4. Othman B, Monem F (2001). Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria. Infection, 29: 262-65.
5. Covic A, Lancu L, Apetrei C, Scripcaru D, Volovat C, Mititiuc I, Covic M (1999). Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant, 14: 40-45.
6. Fabrizi F, Poordad FF, Martin P (2002). Hepatitis C infection and the patient with end stage renal disease. Hepatology, 36: 3-10.
7. Jadoul M (2000). Epidemiology and mechanisms of transmission of the hepatitis C virus in hemodialysis. Nephrol Dial Transplant, 15[Suppl 8]: 39-41.
8. Cendoroglo Neto M, Draibe SA, Silva AEB, Ferraz ML, Granato C, Pereira CA, Sesso RC, Gaspar AMC, Ajzen H (1995). Incidence and risk factors for hepatitis B virus and hepatitis C virus infection among hemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant, 10: 240-46.
9. Fabrizi F, Bunnapradist S, Lunghi G, Aucella F, Martin P (2004). Epidemiology and clinical significance of hepatotropic infection in dialysis patients. Minerva Urol Nefrol, 56: 249-57.
10. Saxena AK, Panhotra BR, Sundaram DS, Naguib M, Venkateshappa CK, Uzzaman W (2003). Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the Middle East. Am J of Infect Control, 31: 26-33.
11. Kokubo S, Horii T, Yonekawa O, Ozawa N, Mukaide M (2002). A phylogenetic-tree analysis elucidating nosocomial transmission of hepatitis C virus in a haemodialysis unit. J Viral Hepat, 9: 450-54.
12. Hosoglu S, Celen MK, Akalin S, Geyik MF, Soyoral Y, Kara IH (2003). Transmission of hepatitis C by blood splash in to conjunctiva in a nurse. Am J Infect Control, 31: 502-504.
13. Sayiner AA, Zeytinoglu A, Ozkahya M, Erensoy S, Ozacar T, Ok E, Akcicek F, Bilgic A (1999). HCV infection in hemodialysis and CAPD patients. Nephrol Dial Transplant, 14: 256-57.
14. Duckworth GJ, Heptonstall J, Aitken C (1999). Transmission of hepatitis C virus from a surgeon to a patient. The Incident Control Team. Commun Dis Public Health, 2: 188-92.
15. Lemon SM, Walker C, Alter MJ, Yi M (2007). Hepatitis C virus. In: Virology. Eds, DM Knipe, PM Howley. 5th ed, Lippincott Williams & Wilkins. Philadelphia, pp. 1253-304.
16. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL,Jr Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002). Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med, 347: 975-82.
17. Mahdaviani F, Saremi S, Changizi M, Pourfatollah AA, Maghsudlu M (2005). [Prevalence of blood transmitted viral infections in regular and nonregular of Arak blood center in the first six months of year 1383]. Blood, 7: 343-51. Persian.
18. Bdour S (2002). Hepatitis C virus infection in Jordanian haemodialysis units: Serologicl diagnosis and genotyping. J Med Microbiol, 51: 700-704.
19. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L (2004). Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol, 74: 246-52.
20. Abdulkarim AS, Zein NN, Germer JJ, Kolbert CP, Kabbani L, Krajnik KL, Hola A, Agha MN, Tourogman M, Persing DH (1998). Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel Hepatitis C virus subtypes. Am J Trop Med Hyg, 59: 571-76.
21. Hosseini-Moghadam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, Alavian SM (2006). Distribution of Hepatitis C genotypes among hemodialysis patients in Tehran-A multicenter study. J Med Virol, 78: 569-73.
22. Sampietro M, Badalamenti S, Salvadori S, Corbetta N, Graziani G, Como G, Fiorelli G, Ponticelli C (1995). High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: Evidence for nosocomial transmission of HCV. Kidney Int, 47: 911-17.
23. Moreira R, Pinho JR, Fares J, Oba IT, Cardoso MR, Saraceni CP, Granato C (2003). Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies. Can J Microbiol, 49: 503-7.
24. Seme K, Poljak M, Zuzek-Resek S, Debeljak M, Dovc P, Koren S (1997). Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit. Nephron, 77: 273-78.
25. Samimi-Rad K, Shahbaz B (2007). Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia, 13: 156-63.
26. Suliman SM, Fessaha S, EL-Sadig M, El-Hadi B, Lambert S, Fields H, Ghalib HW (2003). Prevalence of hepatitis C virus infection in hemodialysis patients in Sudan. Saudi Med J, 24(7): s138.